Retatrutide × Licensed Peptides - Lab Test, January 2026
Test results
About this test
This independent HPLC-UV/VIS lab test confirms Retatrutide 60mg from Licensed Peptides at >99.80% purity. The analysis was conducted by a third-party ISO 17025:2017 accredited laboratory and reported on January 29, 2026. The tested quantity measured 70.02 mg against a stated label claim of 60 mg.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. Endotoxin testing passed at <5.00 EU/mg via the LAL method, and sterility testing via USP <71> confirmed no growth detected.
The full certificate of analysis and HPLC chromatogram are available for review on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.